Top compounds associated with response to CCDC169-SOHLH2


Feature Type Standardized
Nominal ANOVA
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.11 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.11 0.002
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.1 0.002
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV